Jacobo Rogado

Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

Jacobo Rogado, J.M. Sánchez-Torres, Nuria Romero-Laorden et al. · European Journal of Cancer · 2019 · 261 citations

Life Sciences, Immunology, Oncology +17

Covid-19 and lung cancer: A greater fatality rate?

Jacobo Rogado, Cristina Pangua, Gloria Serrano-Montero et al. · Lung Cancer · 2020 · 139 citations · Full text

Medicine, Infectious Diseases, Oncology +17

Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis

B. Mestre-Gómez, Rosa M. Lorente‐Ramos, Jacobo Rogado et al. · Journal of Thrombosis and Thrombolysis · 2020 · 104 citations · Full text

Medicine, Hematology, Internal Medicine +15

Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid

Jacobo Rogado, Berta Obispo, Cristina Pangua et al. · Clinical & Translational Oncology · 2020 · 93 citations · Full text

Medicine, Infectious Diseases, Oncology +16

A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer

Vilma Pacheco-Barcía, Rebeca Mondéjar Solís, T. France et al. · Pancreatology · 2019 · 81 citations

Medicine, Immunology, Oncology +15